Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
Titel:
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
Auteur:
Aroda, V.R. Ahmann, A. Cariou, B. Chow, F. Davies, M.J. Jódar, E. Mehta, R. Woo, V. Lingvay, I.